Latest Blog Posts Tagged "Tau"
July 29, 2015
Drugs in development that go after the processes, rather than the proteins, involved in Alzheimer's onset may have potential to treat Parkinson's disease, as well.
June 24, 2014
PPMI principal investigator Ken Marek, MD, presented baseline observations from the landmark study at the 18th International Congress of Parkinson's Disease and Movement Disorders earlier this month.
August 27, 2013
The study, which was published in the journal JAMA Neurology, studied the cerebrospinal fluid of people with PD as compared with control volunteers, and found subtle, yet important differences.
August 07, 2013
Recent research has pointed to potential genetic commonalities between those with Alzheimer's and Parkinson's, but a new study finds no evidence to this end.
July 23, 2013
The heterogeneous nature of disease-causing protein aggregates and the various processes that might cause them to "go bad," is the subject of the latest blog from the science journalist and PD patient
November 13, 2012
Over the past few months, one particular Alzheimer's disease (AD) drug target has repeatedly been in the news for all the wrong reasons: a protein called beta amyloid.
October 22, 2012
NeuroPhage Pharmaceuticals announced positive pre-clinical data from studies into NPT001, a compound targeting protein aggregates in the brains of people with both Alzheimer's and Parkinson's disease.
May 03, 2012
In April, more than 30 world leaders in Parkinson's disease (PD) research gathered in New York City for The Michael J. Fox Foundation's (MJFF) annual Scientific Advisory Board (SAB) meeting.